Compare API3 (API3) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
API3 vs Mira — how do they compare? API3 trades at Rp3,298 (market cap Rp284,29M, Rp104,37M 24h volume), while Mira trades at Rp689.35 (market cap Rp220,26M, Rp77,93M 24h volume). The key difference: API3 is the larger of the two by market cap, and Mira's supply is capped (321,5M / 1B MIRA (33%)) while API3's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold API3 for 41 Days and Mira for 22 Days on average.
| API3 | MIRA | |
|---|---|---|
Market Cap | Rp284,29M | Rp220,26M |
Volume (24h) | Rp104,37M | Rp77,93M |
Circulating Supply | 86,4M API3 | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 41 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
API3 is trading at Rp3,333 with a market cap of Rp288.04 million, showing a bearish technical signal driven by moving averages. The current price sits near support at S3 (Rp3,219) and below the pivot point (Rp3,341), indicating short-term weakness. Oscillators are neutral, suggesting potential consolidation. No major protocol updates or ecosystem developments were noted in recent analysis.
Overall outlook is cautious due to bearish momentum and lack of positive catalysts. Key opportunities include potential rebounds from support levels if buying interest emerges. Major risks involve low liquidity, high volatility typical of small-cap tokens, and absence of recent positive news to drive demand.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About API3
API3 is an ERC-20 token based on the Ethereum blockchain. API3's goal is to allow decentralized versions of APIs to be built, managed, and monetized at scales. To achieve this in a fully decentralized way, the incentives of the participants are reconciled through the governance, security, and value capture utilities of the API3 token. The project has a completely open and direct governance model, where any API3 token holder can stake to obtain direct voting privileges in the API3 DAO.
Read more on API3 →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
